Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 3Uterine Anomalies 1Salpingitis 1Prostatic Neoplasms 1Progesterone Resistance 1Primary Ovarian Insufficiency 1Pregnancy, Ectopic 1Obesity 1Leiomyoma 1Infertility, Female 1Infertility 1Hypertension 1Endometritis 1Endometriosis 1Endometrial Neoplasms 1Endometrial Hyperplasia 1

Interventions

Nutrition Assessment 4Bevacizumab 3Lisinopril 2Labetalol 2Hydrochlorothiazide 2Angiotensin-Converting Enzyme Inhibitors 2ziprasidone 1pazopanib 1ganirelix 1enzalutamide 1clevidipine 1bicalutamide 1benazepril 1aliskiren 1Zolpidem 1Warfarin 1Vitamin D 1Vecuronium Bromide 1Vancomycin 1Urine Specimen Collection 1Tumor Necrosis Factors 1Tranexamic Acid 1Tobramycin 1Thiazides 1Therapeutics 1Surveys and Questionnaires 1Sunitinib 1Sulindac 1Standard of Care 1Spironolactone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Hypertension × LHRH, Ac-Nal(1)-Cpa(2)-Trp(3)-Arg(6)-Ala(10)- × Clear all
NCT04327934 2024-02-02

Mechanisms of Hypertension in Women With Polycystic Ovary Syndrome

Yale University

Phase EARLY_PHASE1 Terminated
28 enrolled 17 charts

Hypertension, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡